Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Class A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
23.9M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
837K
-
Shares change
-
+812K
-
Total reported value, excl. options
-
$4.38M
-
Value change
-
+$4.25M
-
Put/Call ratio
-
0.06
-
Number of buys
-
27
-
Price
-
$5.23
Significant Holders of Celularity Inc - Class A Common Stock, $0.0001 par value per share (CELU) as of Q1 2024
33 filings reported holding CELU - Celularity Inc - Class A Common Stock, $0.0001 par value per share as of Q1 2024.
Celularity Inc - Class A Common Stock, $0.0001 par value per share (CELU) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 837K shares
of 23.9M outstanding shares and own 3.49% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (385K shares), GEODE CAPITAL MANAGEMENT, LLC (135K shares), BlackRock Inc. (76.4K shares), Cresset Asset Management, LLC (35K shares), RENAISSANCE TECHNOLOGIES LLC (29.8K shares), NORTHERN TRUST CORP (27.3K shares), STATE STREET CORP (24.9K shares), HB Wealth Management, LLC (24K shares), Royal Bank of Canada (22.5K shares), and IPG Investment Advisors LLC (17.2K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.